Our health and safety policies, which apply to all Avient associates, are to safeguard the health and well- being of each person while at work.

Helps to minimize manufacturing investment while optimizing cross-linking benefits e.g., better thermal resistance.

While these level 1, 2, and DC charging stations must meet critical standards and performance specifications, they also need to be safe, aesthetically pleasing, easy to use, and able to withstand harsh outdoor environments and the rigors of everyday use.

They offer a more sustainable alternative to standard polyolefin grades while achieving equivalent performance including good stiffness, durability, impact resistance and UV stability.

Develop and implement solutions to end plastic waste while supporting AEPW $1.5B investment in key initiatives. 2030 SUSTAINABILITY TARGETS Avient Corporation 5 PRODUCTS 8 W A Y S W E H E L P C U S T O M E R S B E M O R E S U S T A I N A B L E TRENDS IN FOCUS Avient Corporation 6 RECYCLING / CIRCULAR ECONOMY LIGHTWEIGHTING ECO-CONSCIOUS SUSTAINABLE SOLUTIONS FOR THE CIRCULAR ECONOMY Avient Corporation 7 OPTICA™ TONERS FOR PET LACTRA™ SX LIGHT BLOCKING ADDITIVE FOR PET AMOSORB™ OXYGEN SCAVENGER FOR PET JOULE™ & SMARTHEAT™ INFRARED ABSORBER ULTIMATE™ UV LIGHT BARRIER CESA®-NATUR BIO-SOURCED ADDITIVES TRIPLE A™ ACETALDEHYDE SCAVENGER FOR PET IR SORTABLE BLACK FOR RECYCLABLE PACKAGING EZE™ SLIP AGENT FOR PET ONCOLOR™ NATURALS – COLORANTS FOR RECYCLABLE PACKAGING RESOUND™ OM THERMOPLASTIC ELASTOMERS VERSAFLEX™ POST- CONSUMER RECYCLED (PCR) TPE FORMULATIONS AVIENT CYCLEWORKS I N N O V A T I O N C E N T E R T O A D V A N C E T H E C I R C U L A R E C O N O M Y • Laboratory mimics real-world circular recycling in a research environment • Conducts chemistry testing to improve plastics recycling for customers • Screening and evaluation of additive and colorant systems during recycling • Collaboration platform for customers and value chain partners Avient Corporation 8 Avient Corporation 9 AVIENT ENABLES CUSTOMERS’ CIRCULAR ECONOMY GOALS C O L O R M A T R I X ™ P R O C E S S A I D & T O N E R F O R R E C Y C L E D P E T LIGHTWEIGHTING Avient Corporation 10 NYMAX™ NYLON FORMULATIONS HYDROCEROL® CHEMICAL FOAMING AGENTS POLYSTRAND™ TAPES AND LAMINATES COMPLĒT™ LFT ENGINEERED RESINS W H AT ’S H AP P E N IN G AV IE N T S O LU T IO N S PLASTICS ARE: AVIENT SOLUTIONS ENABLE LIGHTWEIGHT DASHBOARD SKINS H Y D R O C E R O L ® F O A M I N G A G E N T S O L U T I O N S Avient Corporation 11 ECO-CONSCIOUS Avient Corporation 12 ONCOLOR™ BRILLIANT METALLIC COLORANTS W H AT ’S H AP P E N IN G ONCOLOR™ WPC CAPSTOCK TECHNOLOGY ZODIAC™ AQUARIUS™ WATER BASED SCREEN PRINTING INKS MAGIQ™ FIBER COLORANTS & ADDITIVES SAFER & CLEANER MATERIALS RESOURCE CONSERVATION HUMAN HEALTH & SAFETY ECO-CONSCIOUS ALTERNATIVES AV I E N T S O LU T IO N S AVIENT ECO-CONSCIOUS SOLUTIONS IMPROVE FACE MASK PERFORMANCE Avient Corporation 13 M A G I Q ™ E L E C T R E T P L U S T E C H N O L O G Y Improved filtration efficiency Protects against aerosols & bacteria particles Increased shelf-life ENERGY INTENSITY 9% DECREASE WASTE INTENSITY 2% DECREASE WATER INTENSITY 20% DECREASE TOTAL CO2 EMISSIONS 29% DECREASE PLANET K E Y P E R F O R M A N C E I N D I C A T O R S 2 0 1 6 - 2 0 1 9 56 ENERGY REDUCTION PROJECTS SAVE 7400+ MT/CO2 ANNUALLY PUNE, INDIAASSESSE, BELGIUM Avient Corporation 14 • Avient is a founding member • Cross value chain collaboration • Driving breakthrough innovations REVENUE FROM SUSTAINABLE SOLUTIONS 2016 2017 2018 2019 2020PF VOC Reduction Reduced Energy Use Bio-derived Content Eco-conscious Renewable Energy Applications Recyclability Reduced Material Requirements Lightweighting $275M $325M $355M $410M $560M (1) Proforma to include a full year of Clariant Masterbatch business acquisitionAvient Corporation 16 Revenue from sustainable solutions expected grow at an 8-12% CAGR into the future (1) THANK YOU Avient Corporation 17

INDUSTRY BULLETIN DISPERSIONS IN HEALTHCARE TECHNOLOGY DESCRIPTION TYPICAL APPLICATIONS Silicone Colorant Dispersions Biocompatible, conformable silicone rubber colorants that deliver lightfastness and aesthetic appeal • 3D medical silicone printing • Anatomical models and surgical guides • External prosthetics and orthotics • Wearable medical devices • Medical ventilation/respiratory masks • Dental and medical tools and equipment • Catheters and tubing • Medical adhesives Silicone Additive Dispersions Silicone additive solutions formulated to provide chemical resistance, durability, and enhanced physical properties Rubber Colorant Dispersions Durable rubber colorants formulated for optimal dispersion and lot-to-lot consistency to promote ease of handling • Medical devices and tools • Vibration and shock control for medical equipment • Drug delivery devices Urethane Colorant Dispersions Versatile urethane colorants that streamline production and enhance quality • Medical packaging • Foam enclosures/support for medical tools and equipment • Medical and surgical devices • Physical therapy tools Epoxy Colorant Dispersions Long-lasting, hygienic epoxy colorants that provide high-cost efficiency, stability, and customization opportunities • Medical adhesives • Healthcare facility floor coatings Vinyl Colorant Dispersions Vinyl colorants developed for applications where dispersion, uniformity, compatibility, and cleanliness are essential • Catheters and tubing • Medical equipment Aqueous Additive Formulations Functional additives stabilized, suspended, and dispersed in water that shorten development cycles, streamline operations, and can be customized to meet specific requirements • Medical gloves • Wound care Electrically Conductive Additives for Silicone Innovative silicone additives to provide high conductivity and lower filler loadings • Wearable medical devices • Neurostimulation electrode pads • Medical tools and equipment Laser Marking Additives for Silicone Dispersions containing laser absorbers and color formers that eliminate the need for secondary etching while promoting chemical resistance, mechanical property retention, and production efficiency • Medical packaging • 3D medical silicone printing • Anatomical models and surgical guides • External prosthetics and orthotics • Medical ventilation/respiratory masks • Medical devices Surface Modification Additives for Silicone Non-oil based silicone additives that reduce tackiness and enhance smoothness of the cured compound • Catheters and tubing • Dental tools and equipment • Medical adhesives • Medical devices, tools, and equipment Self-Bonding Silicone Silicone compounds able to bond to various substrates without prime coating • Medical tools and equipment • Wearable medical devices • Medical packaging This listing represents standard Avient dispersion technologies and addresses common healthcare applications, but we can work with you to explore additional options.

It also provides context on development timelines, some industries have tight timelines based on annual launch windows while others have a long specification process. Amorphous vs Semi-Crystalline Thermoplastics An amorphous thermoplastic material has no specific molecular structure while a semi-crystalline polymer has some order.   

Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows including, without limitation, any supply chain and logistics issues; changes in laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to achieve strategic objectives and successfully integrate acquisitions, including Avient Protective Materials; an inability to raise or sustain prices for products or services; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; any material adverse changes in the Dyneema Business; our ability to achieve the strategic and other objectives relating to the Dyneema Acquisition, and the possible sale of the Distribution business segment; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions. Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted.

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; our ability to consummate and successfully integrate acquisitions; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions. Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted.